Vancomycin AUC-Guided Dosing

ورودی‌های بالینی بیمار

حداقل ۲۰ — حداکثر ۳۰۰ • واحد: kg

حداقل ۲۵۰ — حداکثر ۴۰۰۰ • واحد: mg

حداقل ۶ — حداکثر ۷۲ • واحد: hours

حداقل ۱ — حداکثر ۱۰۰ • واحد: mg/L

حداقل ۰ — حداکثر ۷۲ • واحد: hours

حداقل ۱ — حداکثر ۱۰۰ • واحد: mg/L

حداقل ۰ — حداکثر ۷۲ • واحد: hours

حداقل ۰.۱۲۵ — حداکثر ۸ • واحد: mg/L

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
auc mic
—ratio
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Below target0–399.9
  • In target400–600
  • Above target600.1–10000
Direct Clinical Answer

The Vancomycin AUC-Guided Dosing calculates calculating standardized physiological indices and stratifying general clinical risk. Key inputs include weight kg. Scores guide individualizing bedside clinical management, scheduling routine follow-up, and monitoring clinical progress. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

AUC-guided vancomycin dosing check via the two-concentration method: elimination rate constant Ke from two timed levels, clearance from Ke × Vd (0.7 L/kg), then AUC24 = total daily dose / clearance. Target AUC24 400-600 mg·h/L (AUC/MIC 400-600) per the 2020 vancomycin guidelines.

Clinical Indication

The Vancomycin AUC-Guided Dosing is indicated for bedside clinical practice to support AUC-guided vancomycin dosing check via the two-concentration method: elimination rate constant Ke from two timed levels, clearance from Ke × Vd (0.7 L/kg), then AUC24 = total daily dose / clearance. Target AUC24 400-600 mg·h/L (AUC/MIC 400-600) per the 2020 vancomycin guidelines.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult ambulatory and hospitalized patient cohorts evaluated for systemic illness, physiologic risk, or diagnostic probability. Clinical application is indicated across General medical-surgical inpatient units, primary care clinics, and ambulatory outpatient facilities.

Limitations & Contraindications

Single-point score values can obscure rapid temporal clinical deterioration; serial clinical reassessment is essential.

Clinical Pearls & Action Plan

Calculated indices must be contextualized alongside complete clinical history, physical exam, and dynamic trajectory.

Formula & Variables:

Ke = ln(C1/C2)/(t2-t1); CL = Ke * 0.7 * weight_kg; AUC24 = (dose_mg * 24/interval_h) / CL

Input Parameters

NameTypeRequiredDescription
weight_kgfloatYesBody weight(kg)
dose_mgfloatYesVancomycin dose per administration(mg)
interval_hfloatYesDosing interval(hours)
level1floatYesFirst measured concentration (earlier)(mg/L)
time1_hfloatYesTime of first level (hours after start of infusion)(hours)
level2floatYesSecond measured concentration (later, lower)(mg/L)
time2_hfloatYesTime of second level (hours after start of infusion)(hours)
micfloatYesPathogen MIC(mg/L)

Score Interpretation & Guidance

RangeStageDescription
0–399.9Below targetAUC below target
400–600In targetAUC in target range
600.1–10000Above targetAUC above target

Evidence-Based References (EBM)

  • Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious MRSA infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm. 2020;77(11):835-864. (AUC/MIC 400-600 target)

Related calculators